Edesa Biotech, Inc. Common Shares EDSA
$5.46
-22.99%
at last close
Market Cap$63.04 million
P/E Ratio—
Div Yield—
Volume764.9K
52-Week Range
$0.72$20.32
Key Stats
- Today's Range
- $5.01 – $7.61
- 50-Day Range
- $5.01 – $20.32
- 52-Week Range
- $0.72 – $20.32
- Volume
- 765K shs
- Average Volume
- 864K shs
- Market Cap
- $63.04 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.22%
- Days to Cover
- 1.00
About Edesa Biotech, Inc. Common Shares
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
Related Stocks
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.